跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRISEQUENS COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TRISEQUENS COMPRIMIDOS RECUBIERTOS
Approved
STANDARD
TRISEQUENS COMPRIMIDOS RECUBIERTOS
Novo Nordisk Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 17, 2023
Approval ID
aea6944d64f944b5
Company
Novo Nordisk Pharma
Type
Standard
Approval Details
Approval Id
aea6944d64f944b5
Drug Cima Aemps Name
TRISEQUENS COMPRIMIDOS RECUBIERTOS
Register Number
BE156134IP
Holder Company Name
Novo Nordisk Pharma
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-10-17
Dosage Form
COMPRIMIDO RECUBIERTO
Dose
2mg - 2mg/1mg - 1mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novo Nordisk Pharma
Active Ingredients
ESTRADIOL HEMIHIDRATO
1,030 mg
NORETISTERONA ACETATO
1,000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 17, 2023
Approval ID
aea6944d64f944b5
Type
Standard
Back to CIMA-AEMPS Approvals